Swapping Assets Now Down To Execution For GSK And Novartis
This article was originally published in The Pink Sheet Daily
Executive Summary
Being successful with products originally marketed by the other will be key to the future growth and bragging rights for two leading European Big Pharmas, GlaxoSmithKline and Novartis.